Literature DB >> 7461720

The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration.

A A Wadee, R Sher.   

Abstract

Incubation of sensitized mononuclear cells from patients with schistosomiasis with specific antigen containing a suspension of viable Schistosoma haematobium ova resulted in the release of a soluble factor which was chemotactic for eosinophils. Production of this substance was detectable at 24 h and demonstrated peak chemotactic activity after 2 days in culture. The chemotactic potential was dose-dependent and attracted eosinophils obtained from patients with schistosomiasis or allergic diathesis. Human neutrophil motility was unaffected by this chemoattractant. Preliminary studies demonstrated that the chemotactic factor is a heat-stable substance with peak activity associated with a molecular weight of approximately 42,000. These findings may reflect an in vitro correlate of cell-mediated immunity and may indicate a role played by the lymphocyte in the control of eosinophil function in human biology.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7461720      PMCID: PMC1458290     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells.

Authors:  A B Kay; J M McVie; A E Stuart; A Krajewski; L W Turnbull
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

2.  Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter.

Authors:  B M Greene; D G Colley
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Human skin responses to products of concanavalin A-activated lymphocytes.

Authors:  H Valdimarsson; N J Gross
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

5.  Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin.

Authors:  D G Colley
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

6.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

7.  The lymphokine eosinophil stimulation promoter and human schistosomiasis mansoni.

Authors:  J W Kazura; A A Mahmoud; K S Karb; K S Warren
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

8.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

9.  In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils.

Authors:  S Cohen; P A Ward
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  4 in total

1.  Eosinophil chemotactic lymphokine produced by egg-associated granulomas in murine schistosomiasis japonicum.

Authors:  M Owhashi; H Maruyama; Y Nawa
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis.

Authors:  Louis H Stein; Kevin M Redding; James J Lee; Thomas J Nolan; Gerhard A Schad; James B Lok; David Abraham
Journal:  J Innate Immun       Date:  2009-08-05       Impact factor: 7.349

3.  Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy.

Authors:  P Pinkston; V K Vijayan; T B Nutman; W N Rom; K M O'Donnell; M J Cornelius; V Kumaraswami; V J Ferrans; T Takemura; G Yenokida
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  The enhancement of eosinophil function by lymphocyte supernatants.

Authors:  R Sher; A Wadee; M Joffe
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.